Effect of a pharmacist-managed hypertension program on health system costs: an evaluation of the Study of Cardiovascular Risk Intervention by Pharmacists-Hypertension (SCRIP-HTN)

Pharmacotherapy
Sherilyn K D HouleRoss T Tsuyuki

Abstract

To quantify the potential cost savings of a community pharmacy-based hypertension management program based on the results of the Study of Cardiovascular Risk Intervention by Pharmacists-Hypertension (SCRIP-HTN) study in terms of avoided cardiovascular events-myocardial infarction, stroke, and heart failure hospitalization, and to compare these cost savings with the cost of the pharmacist intervention program. An economic model was developed to estimate the potential cost avoidance in direct health care resources from reduced cardiovascular events over a 1-year period. The SCRIP-HTN study found that patients with diabetes mellitus and hypertension who were receiving the pharmacist intervention had a greater mean reduction in systolic blood pressure of 5.6 mm Hg than patients receiving usual care. For our model, published meta-analysis data were used to compute cardiovascular event absolute risk reductions associated with a 5.6-mm Hg reduction in systolic blood pressure over 6 months. Costs/event were obtained from administrative data, and probabilistic sensitivity analyses were performed to assess the robustness of the results. Two program scenarios were evaluated-one with monthly follow-up for a total of 1 year with sustained b...Continue Reading

References

Jan 20, 2000·The New England Journal of Medicine·UNKNOWN Heart Outcomes Prevention Evaluation Study InvestigatorsG Dagenais
Feb 24, 2001·Italian heart journal. Supplement : official journal of the Italian Federation of Cardiology·E Eleuteri
Sep 22, 2001·The New England Journal of Medicine·B M BrennerUNKNOWN RENAAL Study Investigators
Nov 21, 2001·Pharmacotherapy·M P Okamoto, R K Nakahiro
Nov 7, 2002·Current Hypertension Reports·J Jaime Caro, Karen Lee
Feb 18, 2003·Pharmacotherapy·Jeff E BorensteinScott R Weingarten
Mar 12, 2003·Circulation·J Malcolm O ArnoldUNKNOWN HOPE Investigators
Nov 15, 2003·Lancet·Fiona Turnbull, UNKNOWN Blood Pressure Lowering Treatment Trialists' Collaboration
Jan 21, 2006·Journal of General Internal Medicine·Alan J ZillichBarry L Carter
Jan 15, 2008·Journal of the American Pharmacists Association : JAPhA·Barry A BuntingSusan E Sutherland
Mar 25, 2008·Journal of the American Pharmacists Association : JAPhA·Brian J IsettsRobert J Cipolle
Jun 7, 2008·Health Policy·Minna Heleena VäänänenMarja Airaksinen

❮ Previous
Next ❯

Citations

Feb 25, 2014·International Journal of Clinical Pharmacy·Carissa A HanesBandana Saini
Nov 29, 2015·International Journal of Clinical Pharmacy·Richard S BourneRaliat Onatade
Jan 31, 2015·Research in Social & Administrative Pharmacy : RSAP·Patti NapierRhiannon Braund
Oct 4, 2015·Diabetic Medicine : a Journal of the British Diabetic Association·Y WangY Ko
Nov 22, 2013·The Annals of Pharmacotherapy·Brandi E FranklinDebbie C Byrd
Nov 29, 2013·The Annals of Pharmacotherapy·Amanda Howard-ThompsonKatie J Suda
Nov 11, 2016·Canadian Pharmacists Journal : CPJ = Revue Des Pharmaciens Du Canada : RPC·Sherilyn K D HouleRoss T Tsuyuki
Mar 22, 2018·Pharmacy : Journal of Pharmacy, Education and Practice·Meagen M Rosenthal, Erin R Holmes
Aug 10, 2017·The Journal of International Medical Research·Kimberly D BrunisholzGregory Parkin
Oct 31, 2014·Stroke; a Journal of Cerebral Circulation·James F MeschiaUNKNOWN Council on Hypertension
Oct 17, 2019·Pharmacy : Journal of Pharmacy, Education and Practice·Linda AwdishuCandis M Morello
Dec 7, 2019·The Cochrane Database of Systematic Reviews·Liz SteedR T Walton
Jan 11, 2020·International Journal of Clinical Pharmacy·Zhuo MaLiHong Liu
Apr 3, 2019·Journal of Pharmaceutical Policy and Practice·Suzete CostaAna Paula Martins
Aug 31, 2017·BMC Health Services Research·Jorge FélixCarlos Maurício Barbosa
Jan 3, 2021·International Journal of Clinical Pharmacy·Sophie KhettarAudrey Janoly-Dumenil

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cardiovascular Disease Pathophysiology

Cardiovascular disease involves several different processes that contribute to the pathological mechanism, including hyperglycemia, inflammation, atherosclerosis, hypertension and more. Vasculature stability plays a critical role in the development of the disease. Discover the latest research on cardiovascular disease pathophysiology here.

Related Papers

The Journal of Clinical Hypertension
Thomas D Giles
The Journal of Clinical Hypertension
Borut Cizman, Raymond R Townsend
Hypertension Research : Official Journal of the Japanese Society of Hypertension
Katsuyuki Ando, Toshiro Fujita
© 2021 Meta ULC. All rights reserved